Metraipolis › archive › dc_7202036d4ea3
FAP-Targeted Radionuclide Therapy: Mechanisms, Clinical Applications, and Combination Strategies — Europe PMC PMID:42511954
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42511954
- DOI
- 10.3390/biomedicines14071479
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T14:21:05.275Z
- SHA-256 of the archived text
dd88eda42a5c3681f765041ae2fd16d0bb1143c8a85a05cd0f5bd1af1d0e461b- Stable URL of this page
https://metraipolis.com/documento/dc_7202036d4ea3
How to cite
FAP-Targeted Radionuclide Therapy: Mechanisms, Clinical Applications, and Combination Strategies — Europe PMC PMID:42511954 — Europe PMC (en), https://europepmc.org/article/MED/42511954 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7202036d4ea3 (Metraipolis archive dc_7202036d4ea3, sha256 dd88eda42a5c3681f765041ae2fd16d0bb1143c8a85a05cd0f5bd1af1d0e461b)
BibTeX
@misc{dc7202036d4ea3,
title = {FAP-Targeted Radionuclide Therapy: Mechanisms, Clinical Applications, and Combination Strategies — Europe PMC PMID:42511954},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42511954},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7202036d4ea3; sha256 dd88eda42a5c3681f765041ae2fd16d0bb1143c8a85a05cd0f5bd1af1d0e461b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42511954. Agents can read the archived copy with the MCP tool read_document.